GARS Antikörper (AA 35-305)
Kurzübersicht für GARS Antikörper (AA 35-305) (ABIN7091173)
Target
Alle GARS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 35-305
-
Homologie
- Human
-
Immunogen
- Recombinant human GARS between 35-305 amino acids.
-
-
-
-
Applikationshinweise
- WB 1:300-5000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.5 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- GARS (Glycyl-tRNA Synthetase (GARS))
-
Andere Bezeichnung
- GARS
-
Hintergrund
-
Synonyms: AP 4 A synthetase, Charcot Marie Tooth neuropathy 2D, Charcot Marie Tooth neuropathy neuronal type D, CMT2D, Diadenosine tetraphosphate synthetase, DSMAV, EC 6.1.1.14, Glycine tRNA ligase, Glycyl tRNA synthetase, GlyRS, HMN5, SMAD1, GARS_HUMAN.
Background: GARS synthetase catalyzes the ligation of glycine with glycyl-tRNA using ATP and its mutation induces Charcot-Marie-Tooth (CMT) disease.
-
Gen-ID
- 2617
-
UniProt
- P41250
-
Pathways
- Ribonucleoside Biosynthetic Process
Target
-